Price target
84.060.000.00%
The 26 analysts offering 1 year price forecasts for BM8 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 30 analysts giving stock ratings to BM8 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
BM8 EPS for the last quarter is 0.47 CHF despite the estimation of 0.45 CHF. In the next quarter EPS is expected to reach 0.49 CHF. Track more of BIOMARIN PHARMA financials and stay on top of what is up with the company.
In the next quarter BIOMARIN PHARMA revenue is expected to reach 629.02 M CHF. Check out BIOMARIN PHARMA revenue and earnings and make informed decisions.
According to analysts, BM8 price target is 84.06 CHF with a max estimate of 110.49 CHF and a min estimate of 56.55 CHF. Check if this forecast comes true in a year, meanwhile watch BIOMARIN PHARMA stock price chart and keep track of the current situation with BM8 news and stock market news.
We've gathered opinions of 30 analysts rating BM8 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.